Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro

Yamaguchi,Masayoshi; Murata,Tomiyasu

doi:10.3892/ijmm.2015.2164

Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro

Authors:
- Masayoshi Yamaguchi
- Tomiyasu Murata
View Affiliations

Affiliations: Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA, Department of Analytical Neurosciences, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Aichi, Japan
Published online on: April 1, 2015 https://doi.org/10.3892/ijmm.2015.2164
Pages: 1773-1778

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Regucalcin plays a pivotal role as a suppressor protein in signal transduction in various types of cells and tissues. The regucalcin gene is localized on the X chromosome. and its expression has been shown to be suppressed in various types of tumor tissue in animal and human subjects, suggesting a potential role of regucalcin in carcinogenesis. This study was undertaken to determine the effects of exogenous regucalcin on the proliferation of cloned human pancreatic cancer MIA PaCa-2 cells in vitro. The proliferation of the MIA PaCa-2 cells was suppressed following culture with regucalcin (0.01‑10 nM). Such an effect was also observed in pancreatic cancer Pt45P1 cells, that highly expressed tissue factor (high TF), or Pt45P1 cells, that highly expressed alternativly spliced variants of tissue factor (asTF). In the MIA PaCa-2 cells, the suppressive effects of regucalcin on cell proliferation were not enhanced either in the presence of tumor necrosis factor‑α (TNF‑α), or in the presence of Bay K 8644, PD98059, staurosporine, wortmannin or 5,6‑dichloro‑1‑β‑D‑ribofuranosylbenzimidazole (DRB). However, this was not the case for gemcitabine, which was shown to suppress cell proliferation. Exogenous regucalcin did not cause apoptotic cell death in the MIA PaCa-2 cells in vitro. These findings demonstrate that exogenous regucalcin exerts suppressive effects on the proliferation of human pancreatic MIA PaCa-2 cells and that these effects are mediated through the inhibition of various signaling pathways related to nuclear factor-κB (NF-κB), extracellular signal-regulated kinase (ERK), protein kinase C, calcium signaling, phosphatidylinositol 3-kinase (PI3K) or nuclear transcription activity in vitro. Our data suggest that exogenous regucalcin exerts suppressive effects on the proliferation of human pancreatic cancer cells.

View Figures

View References

1	Yamaguchi M and Yamamoto T: Purification of calcium binding substance from soluble fraction of normal rat liver. Chem Pharma Bull (Tokyo). 26:1915–1918. 1978. View Article : Google Scholar
2	Yamaguchi M and Sakurai T: Inhibitory effect of calcium-binding protein regucalcin on Ca²⁺-activated DNA fragmentation in rat liver nuclei. FEBS Lett. 279:281–284. 1991. View Article : Google Scholar : PubMed/NCBI
3	Shimokawa N and Yamaguchi M: Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver. FEBS Lett. 327:251–255. 1993. View Article : Google Scholar : PubMed/NCBI
4	Misawa H and Yamaguchi M: The gene of Ca²⁺-binding protein regucalcin is highly conserved in vertebrate species. Int J Mol Med. 6:191–196. 2000.PubMed/NCBI
5	Yamaguchi M: Role of regucalcin in calcium signaling. Life Sci. 66:1769–1780. 2000. View Article : Google Scholar : PubMed/NCBI
6	Yamaguchi M: Role of regucalcin in maintaining cell homeostasis and function (Review). Int J Mol Med. 15:371–389. 2005.PubMed/NCBI
7	Yamaguchi M: Regucalcin and cell regulation: role as a suppressor in signal transduction. Mol Cell Biochem. 353:101–137. 2011. View Article : Google Scholar : PubMed/NCBI
8	Shimokawa N, Matsuda Y and Yamaguchi M: Genomic cloning and chromosomal assignment of rat regucalcin gene. Mol Cell Biochem. 151:157–163. 1995. View Article : Google Scholar : PubMed/NCBI
9	Thiselton DL, McDowall J, Brandau O, Ramser J, d’Esposito F, Bhattacharya SS, Ross MT, Hardcastle AJ and Meindl M: An integrated, functionally annotated gene map of the DXS8026-ELK1 internal on human Xp11.3-Xp11.23: Potential hotspot for neurogenetic disorders. Genomics. 79:560–572. 2002. View Article : Google Scholar : PubMed/NCBI
10	Yamaguchi M, Makino R and Shimokawa N: The 5’ end sequences and exon organization in rat regucalcin gene. Mol Cell Biochem. 165:145–150. 1996. View Article : Google Scholar : PubMed/NCBI
11	Yamaguchi M: The transcriptional regulation of regucalcin gene expression. Mol Cell Biochem. 346:147–171. 2011. View Article : Google Scholar
12	Yamaguchi M: Hormonal regulation of regucalcin gene expression: Involvement in cell metabolism. Horm Stud. 1:12013. View Article : Google Scholar
13	Yamaguchi M: Role of regucalcin in cell nuclear regulation: Involvement as a transcription factor. Cell Tissue Res. 354:331–341. 2013. View Article : Google Scholar : PubMed/NCBI
14	Yamaguchi M: Suppressive role of regucalcin in liver cell proliferation: Involvement in carcinogenesis. Cell Prolif. 46:243–253. 2013. View Article : Google Scholar : PubMed/NCBI
15	Yamaguchi M: The anti-apoptotic effect of regucalcin is mediated through multisignaling pathways. Apoptosis. 18:1145–1153. 2013. View Article : Google Scholar : PubMed/NCBI
16	Yamaguchi M: Regucalcin and metabolic disorders: Osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats. Mol Cell Biochem. 341:119–133. 2010. View Article : Google Scholar : PubMed/NCBI
17	Yamaguchi M and Murata T: Involvement of regucalcin in lipid metabolism and diabetes. Metabolism. 62:1045–1051. 2013. View Article : Google Scholar : PubMed/NCBI
18	Yamaguchi M: Regucalcin as a potential biomarker for metabolic and neuronal diseases. Mol Cell Biochem. 391:157–166. 2014. View Article : Google Scholar : PubMed/NCBI
19	Yamaguchi M: Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy. J Cancer Res Clin Oncol. Sep 18–2014.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
20	Murata T and Yamaguchi M: Alternatively spliced variants of the regucalcin gene in various human normal and tumor tissues. Int J Mol Med. 34:1141–1146. 2014.PubMed/NCBI
21	Misawa H, Inagaki S and Yamaguchi M: Suppression of cell proliferation and deoxyribonucleic acid synthesis in cloned rat hepatoma H4-II-E cells overexpressing regucalcin. J Cell Biochem. 84:143–149. 2001. View Article : Google Scholar
22	Ninomiya I, Yamazaki K, Oyama K, Hayashi H, Tajima H, Kitagawa H, Fushida S, Fujimura T and Ohta T: Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells. Oncol Lett. 8:2709–2714. 2014.PubMed/NCBI
23	Sipos B, Möser S, Kalthoff H, Török V, Löhr M and Klöppel G: A comprehensive characterization of pancreatic ductal carcinoma cell lines: Towards the establishment of an in vitro reseach platform. Virchows Arch. 442:444–452. 2003.PubMed/NCBI
24	Yamaguchi M and Isogai M: Tissue concentration of calcium-binding protein regucalcin in rats by enzyme-linked immunoadsorbent assay. Mol Cell Biochem. 122:65–68. 1993. View Article : Google Scholar : PubMed/NCBI
25	Lee ZH, Kwack K, Kim KK, Lee SH and Kim HH: Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of NF-kappaB. Mol Pharmacol. 58:1536–1545. 2000.PubMed/NCBI
26	Cano-Abad MF, Villarroya M, García AG, Gabilan NH and Lopez MG: Calcium entry through L-type calcium channels causes mitochondrial disruption and chromaffin cell death. J Biol Chem. 276:39695–39704. 2001. View Article : Google Scholar : PubMed/NCBI
27	Chen S, Wang Y, Ruan W, Wang X and Pan C: Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity. Oncol Lett. 8:2333–2339. 2014.PubMed/NCBI
28	Chen QW, Edvinsson and Xu CB: Role of ERK/MAPK in endothelin receptor signaling in human aortic smoth muscle cells. BMC Cell Biol. 10:522009. View Article : Google Scholar
29	Serrano-Nascimento C, da Silva Teixeira S, Nicola JP, Nachbar RT, Masini-Repiso AM and Nunes MT: The acute inhibitory effect of iodide excess on sodium/iodide symporter expression and activity involves the PI3K/Akt signaling pathway. Endocrinology. 155:1145–1156. 2014. View Article : Google Scholar : PubMed/NCBI
30	Palangat M, Grass JA, Langelier MF, Coulombe B and Landick R: The RPB2 flap loop of human RNA polymerase II is dispensable for transcription initiation and elongation. Mol Cell Biol. 31:3312–3325. 2011. View Article : Google Scholar : PubMed/NCBI
31	Tang SC and Chen YC: Novel therapeutic targets for pancreatic cancere. World J Gastroenterol. 20:10825–10844. 2014. View Article : Google Scholar : PubMed/NCBI
32	Maia C, Santos C, Schmitt F and Socorro S: Regucalcin is under- expressed in human breast and prostate cancers: Effect of sex steroid hormones. J Cell Biochem. 107:667–676. 2009. View Article : Google Scholar : PubMed/NCBI
33	Yamaguchi M and Daimon Y: Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: Involvement of intracellular signaling factors and cell cycle-related genes. J Cell Biochem. 95:1169–1177. 2005. View Article : Google Scholar : PubMed/NCBI
34	Nakagawa T, Sawada N and Yamaguchi M: Overexpression of regucalcin suppresses cell proliferation of cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int J Mol Med. 16:637–643. 2005.PubMed/NCBI
35	Tsurusaki Y and Yamaguchi M: Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem. 90:619–626. 2003. View Article : Google Scholar : PubMed/NCBI
36	Tsurusaki Y and Yamaguchi M: Role of regucalcin in liver nuclear function: Binding of regucalcin to nuclear protein or DNA and modulation of tumor-related gene expression. Int J Mol Med. 14:277–281. 2004.PubMed/NCBI
37	Yamaguchi M, Mori S and Kato S: Calcium-binding protein regucalcin is an activator (Ca²⁺-Mg²⁺)-adenosine triphosphatase in the plasma membranes of rat liver. Chem Pharm Bull (Tokyo). 36:3532–3539. 1988. View Article : Google Scholar